GoldenGolden
Advanced Search
Synapse Biomedical

Synapse Biomedical

A company commercializing the NeuRx® Diaphragm Pacing System (DPS).

All edits

Edits on 28 Jun, 2021
Erin Scherfner"prospector:338:165414"
Erin Scherfner edited on 28 Jun, 2021
Edits made to:
Infobox (+3 properties)
Infobox
Country
United States
Edits on 27 Mar, 2020
Arthur Smalley
Arthur Smalley edited on 27 Mar, 2020
Edits made to:
Article (+258 characters)
Article

In September 2011 Synapse Biomedical announced that the U.S. Food and Drug Administration (FDA) approved its NeuRx DPS for treating amyotrophic lateral sclerosis (ALS) patients who have stimulatable diaphragms and are experiencing chronic hypoventilation.

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 27 Mar, 2020
Edits made to:
Article (+31/-31 characters)
Article

Synapse Biomedical Inc (SBI) is a company founded in September 2002 by Anthony Ignagni to commercialize the NeuRx Diaphragm Pacing System (DPS). The electrical stimulation system was developed over a twenty-year period at Case Western Reserve UniversityCase Western Reserve University and the University Hospitals of Cleveland for the treatment of chronic respiratory insufficiency. The innovative system allows technology to meet clinical needs in spinal cord injuries, diaphragm conditioning in muscular dystrophies (such as ALS) and respiratory short-term intensive care settings.

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 27 Mar, 2020
Edits made to:
Article (+20/-20 characters)
Article

Synapse Biomedical Inc (SBI) is a company founded in September 2002 by Anthony Ignagni to commercialize the NeuRx Diaphragm Pacing System (DPS). The electrical stimulation system was developed over a twenty-year period at Case Western Reserve University and the University HospitalsUniversity Hospitals of Cleveland for the treatment of chronic respiratory insufficiency. The innovative system allows technology to meet clinical needs in spinal cord injuries, diaphragm conditioning in muscular dystrophies (such as ALS) and respiratory short-term intensive care settings.

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 27 Mar, 2020
Edits made to:
Article (+15/-15 characters)
Article

Synapse Biomedical Inc (SBI) is a company founded in September 2002 by Anthony IgnagniAnthony Ignagni to commercialize the NeuRx Diaphragm Pacing System (DPS). The electrical stimulation system was developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland for the treatment of chronic respiratory insufficiency. The innovative system allows technology to meet clinical needs in spinal cord injuries, diaphragm conditioning in muscular dystrophies (such as ALS) and respiratory short-term intensive care settings.

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 27 Mar, 2020
Edits made to:
Article (+5/-5 characters)
Article

Synapse Biomedical's headquarters are located in Oberlin, Ohio. The company has a European office located in the Enghien-Les-Bains suburb of ParisParis, France.

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 27 Mar, 2020
Edits made to:
Article (+13/-13 characters)
Article

Synapse Biomedical's headquarters are located in Oberlin, OhioOberlin, Ohio. The company has a European office located in the Enghien-Les-Bains suburb of Paris, France.

Arthur Smalley
Arthur Smalley edited on 27 Mar, 2020
Edits made to:
Infobox (+2 properties)
Article (+892 characters)
Article

Synapse Biomedical Inc (SBI) is a company founded in September 2002 by Anthony Ignagni to commercialize the NeuRx Diaphragm Pacing System (DPS). The electrical stimulation system was developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland for the treatment of chronic respiratory insufficiency. The innovative system allows technology to meet clinical needs in spinal cord injuries, diaphragm conditioning in muscular dystrophies (such as ALS) and respiratory short-term intensive care settings.

Synapse Biomedical's headquarters are located in Oberlin, Ohio. The company has a European office located in the Enghien-Les-Bains suburb of Paris, France.

The company has partnered with treatment centers in 24 countries that have skilled Board Certified Laparoscopic Surgeons qualified to perform the NeuRx DPS® implantation procedure.

Infobox
Investors
Edits on 25 Mar, 2020
Golden AI
Golden AI edited on 25 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 25 Mar, 2020
Edits made to:
Infobox (+1 properties)
Arthur Smalley
Arthur Smalley edited on 25 Mar, 2020
Edits made to:
Table (+3 cells) (+153/-12 characters)
Topic thumbnail

Synapse Biomedical

A company commercializing the NeuRx® Diaphragm Pacing System (DPS).

Table

Name
Role
LinkedIn

Anthony R. Ignagni

President, CEO & Co-Founder

Dave M ahiloMahilo

Vice President of Quality

Moustapha D iopDiop

Chief Operating Officer & Managing Director-Europe

Arthur Smalley
Arthur Smalley edited on 25 Mar, 2020
Edits made to:
Infobox (+8 properties)
Table (+4 rows) (+8 cells) (+202 characters)
Table

Name
Role
LinkedIn

Anthony R. Ignagni

President, CEO & Co-Founder

Dave M ahilo

Vice President of Quality

Moustapha D iop

Chief Operating Officer & Managing Director-Europe

Timothy Crish

V.P. of Product Development & Operations

Infobox
Email address
info@synapsebiomedical.com
Founded date
September 2002
Full address
300 Artino St., Oberlin, OH 44074
Headquarters
Edits on 24 Mar, 2020
Arthur Smalley
Arthur Smalley edited on 24 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Arthur Smalley
Arthur Smalley edited on 24 Mar, 2020
Edits made to:
Infobox (+3 properties)
Description (+67 characters)
Categories (+1 topics)
Topic thumbnail

Synapse Biomedical

A company commercializing the NeuRx® Diaphragm Pacing System (DPS).

Infobox
Location
Categories
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Edits made to:
Infobox (+3 properties)
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:
Topic thumbnail

 Synapse Biomedical

A company commercializing the NeuRx® Diaphragm Pacing System (DPS).

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.